References
- Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013; 27(4):365-9. https://doi.org/10.1016/j.jdiacomp.2013.03.002
- Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, Tsoukas MA, et al. CS. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(12): 4899-907. https://doi.org/10.1210/jc.2013-2373
- Park MJ, Kim D Il, Choi JH, Heo YR, Park SH. New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro. Cell Signal 2015; 27(9):1831-9. https://doi.org/10.1016/j.cellsig.2015.04.010
- Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi, et al. Irisin stimulates browning of white adipocytes through mitogen activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63(2):514-25. https://doi.org/10.2337/db13-1106
-
Liu S, Du F, Li X, Wang M, Duan R, Zhang J, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic
$\beta$ cells. PLoS One 2017; 12(4):e0175498. https://doi.org/10.1371/journal.pone.0175498 - Bostrom P, Wu J, Jedrychowski M.P, Korde A, Ye L, Lo J.C, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-8. https://doi.org/10.1038/nature10777
- Kozakova M, Balkau B, Morizzo C. Physical activity, adiponectin, and cardiovascular structure and function. Heart Vessels 2013; 28(1): 91-100. https://doi.org/10.1007/s00380-011-0215-4
- Chen N, Li Q, Liu J, Jia S. Irisin, an exercise-induced myokine as a metabolic regulator: an updated narrative review. Diabetes Metab Res Rev. 2016;32(1):51-9. https://doi.org/10.1002/dmrr.2660
- Roca-Rivada A, Castelao C, Senin LL. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013; 8(4): e60563. https://doi.org/10.1371/journal.pone.0060563
-
Schumacher MA, Chinnam N, Ohashi T, Shah RS, Erickson HP. The structure of irisin reveals a novel intersubunit
$\beta$ -sheet fibronectin (FNIII) dimer: implications for receptor activation. J Biol Chem. 2013;22:288(47):33738-44. https://doi.org/10.1074/jbc.M113.516641 - Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, et al. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J. 2014; 281(3): 739–49. https://doi.org/10.1111/febs.12619
- Xu B. BDNF (I)rising from exercise. Cell Metab. 2013; 18(5): 612–4. https://doi.org/10.1016/j.cmet.2013.10.008
- Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab. 2013; 98(4): 769–78. https://doi.org/10.1210/jc.2012-2270
- Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, et al. Irisin Stimulates Browning of White Adipocytes through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling. Diabetes 2014;63(2):514-25. https://doi.org/10.2337/db13-1106
- Rizk FH, Elshweikh SA, Abd El-Naby AY. Irisin levels in relation to metabolic and liver functions in Egyptian patients with metabolic syndrome. Can J Physiol Pharmacol. 2016; 94(4):359-62. https://doi.org/10.1139/cjpp-2015-0371
- Jung, UJ, Choi, MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci.2014; 15 (4): 6184–6223. https://doi.org/10.3390/ijms15046184
- Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications. 2013; 27(4):365-9. https://doi.org/10.1016/j.jdiacomp.2013.03.002
- Gouni-Berthold I, Berthold HK, Huh JY, Berman R, Spenrath N, Krone W, et al. Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo. PLoS One 2013; 8:e72858. https://doi.org/10.1371/journal.pone.0072858
- Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2014; 592 (5):1091–107. https://doi.org/10.1113/jphysiol.2013.264655
- Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9(5):367–77 https://doi.org/10.1038/nrm2391
-
Castillo-Quan JI. From white to brown fat through the
$PGC-1{\alpha}$ -dependent myokine irisin: implications for diabetes and obesity. Dis Model Mech. 2012; 5(3): 293-5. https://doi.org/10.1242/dmm.009894 - Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen CA. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One.2013; 8(4):e60563. https://doi.org/10.1371/journal.pone.0060563
- Yan B, Shi X, Zhang H, Pan L, Ma Z, Liu S, et al. Association of serum irisin with metabolic syndrome in obese Chinese adults. PLoS One 2014; 9(4):e94235. https://doi.org/10.1371/journal.pone.0094235
- Xiong XQ, Chen D, Sun HJ, Ding L, Wang JJ, Chen Q, et al. FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. Biochim et Biophysica Acta. 2015; 1867-75.
- Chen JQ, Huang YY, Gusdon AM, Qu S. Irisin: a new molecular marker and target in metabolic disorder. Lipids in Health and Disease 2015; 14(2): 1476-511.
-
Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, et al. FGF21 regulates
$PGC-1{\alpha}$ and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012; 26: 271-81. https://doi.org/10.1101/gad.177857.111 - Liu JJ, Liu S, Wong MD, Tan CS, Tavintharan S, Sum CF, et al. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications 2014; 28(2):208-13. https://doi.org/10.1016/j.jdiacomp.2013.09.011
- Park KH, Zaichenko L, Brinkoetter M, Thankkar B, Shain-Efe A, Joung KE, et al Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab. 2013; 98 (12):4899-907. https://doi.org/10.1210/jc.2013-2373
- Tang H, Yu R, Liu S, Huwatibieke B, Li Z, et al. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling. EBioMedicine 2016;139-48.
- Liu TY, Shi CX, Gao R, Sun HJ, Xiong XQ, Ding L, et al. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Clin Sci(Lond). 2015; 129: 839–50. https://doi.org/10.1042/CS20150009
-
Liu S, Du F, Li X, Wang M, Duan R Zhang J, et al. Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic
$\beta$ cells. PLoS One.2017; 12(4):e0175498 https://doi.org/10.1371/journal.pone.0175498 - Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, et al. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis. PLoS One 2014; 9(10): e110273. https://doi.org/10.1371/journal.pone.0110273
- Moon HS, Dincer F, Mantzoros CS. Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism. 2013; 62(8): 1131-6. https://doi.org/10.1016/j.metabol.2013.04.007
- Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. 2015; 243(2):438-48. https://doi.org/10.1016/j.atherosclerosis.2015.10.020
- Qiao X, Nie Y, Ma Y, Chen Y, Cheng R, Yin W, et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016; 6: 18732 https://doi.org/10.1038/srep18732
- Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015; 87: 138-47. https://doi.org/10.1016/j.yjmcc.2015.07.015
- Kuloglu T, Aydin S, Eren MN, Yilmaz M, Sahin I, Kalayci M, et al. Irisin: a potentially candidate marker for myocardial infarction. Peptides 2014; 55:85-91. https://doi.org/10.1016/j.peptides.2014.02.008
- Emanuele E, Minoretti P, Pareja-Galeano H, Sanchis-Gomar F, Garatachea N, Lucia A. Serum irisin levels, precocious myocardial infarction, and healthy exceptional longevity. Am J Med 2014; 127 (9):888-90. https://doi.org/10.1016/j.amjmed.2014.04.025
- Aronis KN, Moreno M, Polyzos SA, Moreno-Navarrete JM, Ricart W, Delgado E, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes (Lond) 2015; 39(1):156-61. https://doi.org/10.1038/ijo.2014.101
- Aydin S, Kuloglu T, Aydin S, Eren MN, Celik A, Yilmaz M, et al Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 2014; 52:68-73. https://doi.org/10.1016/j.peptides.2013.11.024
- Qiao X, Nie Y, Ma Y, Chen Y, Cheng R, Yao Yinrg W. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016; 6: 18732. https://doi.org/10.1038/srep18732
- Wu F, Song H, Zhang Y, Zhang Y, Mu Q, Jiang M, et al Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway. PLoS One. 2015; 10(8): e0134662. https://doi.org/10.1371/journal.pone.0134662
- Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F, et al. Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol cell Cardiol. 2015; 87: 138-147. https://doi.org/10.1016/j.yjmcc.2015.07.015